Noninvasive brain stimulation techniques, including transcranial direct current stimulation, are effective nonpharmacologic treatments for insomnia.

Yet greater awareness of sleep deprivation’s consequences hasn’t translated into a better-rested populace. Data from the CDC ...

Hong Kong-listed, Nanjing, Jiangsu province-based Simcere Pharmaceutical Group Ltd announced on Monday that Quviviq, an ...

A drug used to treat insomnia has protected mice against the buildup of the tau protein found to clump abnormally in neurodegenerative diseases like Alzheimer's. This could lead to new ways to help ...

The Business Research Company's Insomnia Therapeutics Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 The Business Research Company's Latest Report Explores Market ...

CBTi is the front-line treatment Thomas says CBTi is now the front-line treatment for insomnia. “It usually does a good job and has a more lasting effect than medications.” With CBTi, patients ...

In December, the U.S. Food and Drug Administration (FDA) approved a new treatment for people with insomnia, Dayvigo (lemborexant). The drug will be available in 5 or 10 milligram (mg) doses ...

The drug free treatment for insomnia Transcript ... A conservative estimate is that more than 40 per cent of Australians do not get a good night’s sleep.

TOKYO, May 28, 2025--- Eisai Co., Ltd. announced today that the in-house-discovered and developed orexin receptor antagonist DAYVIGO has been approved in China for the treatment of adults with ...

If drugs could be developed to prevent orexin from binding to its receptors, Mignot thought, then people with insomnia would become “narcoleptic for one night”.

CBTi is now the front-line treatment for insomnia, Thomas said: “It usually does a good job and has a more lasting effect than medications.” With CBTi, “we get people to identify those thoughts that ...